Gouissi Anguechia, D.-H.; Bouba, Y.; Semengue, E.N.J.; Ka’e, A.C.; Takou, D.; Ambe Chenwi, C.; Beloumou, G.; Nka, A.D.; Basseck Wome, U.R.; Santoro, M.M.;
et al. Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries. Viruses 2024, 16, 1853.
https://doi.org/10.3390/v16121853
AMA Style
Gouissi Anguechia D-H, Bouba Y, Semengue ENJ, Ka’e AC, Takou D, Ambe Chenwi C, Beloumou G, Nka AD, Basseck Wome UR, Santoro MM,
et al. Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries. Viruses. 2024; 16(12):1853.
https://doi.org/10.3390/v16121853
Chicago/Turabian Style
Gouissi Anguechia, Davy-Hyacinthe, Yagai Bouba, Ezechiel Ngoufack Jagni Semengue, Aude Christelle Ka’e, Désiré Takou, Collins Ambe Chenwi, Grace Beloumou, Alex Durand Nka, Ulrich Roland Basseck Wome, Maria Mercedes Santoro,
and et al. 2024. "Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries" Viruses 16, no. 12: 1853.
https://doi.org/10.3390/v16121853
APA Style
Gouissi Anguechia, D.-H., Bouba, Y., Semengue, E. N. J., Ka’e, A. C., Takou, D., Ambe Chenwi, C., Beloumou, G., Nka, A. D., Basseck Wome, U. R., Santoro, M. M., Ceccherini-Silberstein, F., Chatté, A., Montesano, C., Cappelli, G., Colizzi, V., Ndjolo, A., Mbanya, D., Ndembi, N., Perno, C.-F.,
& Fokam, J.
(2024). Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries. Viruses, 16(12), 1853.
https://doi.org/10.3390/v16121853
